DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

JMP Securities Initiates Coverage On Cue Biopharma with Market Outperform Rating, Announces $22 Price Target

JMP Securities analyst Reni Benjamin initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Market Outperform rating and a $22 price target.

Benzinga · 01/22/2020 11:25

JMP Securities analyst Reni Benjamin initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Market Outperform rating and a $22 price target.